Exane Derivatives’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-190
Closed -$50.8K 705
2020
Q1
$50.8K Sell
190
-750
-80% -$201K 0.01% 332
2019
Q4
$331K Sell
940
-1,063
-53% -$374K 0.06% 194
2019
Q3
$547K Buy
2,003
+893
+80% +$244K 0.1% 152
2019
Q2
$592K Sell
1,110
-309
-22% -$165K 0.1% 144
2019
Q1
$715K Buy
+1,419
New +$715K 0.14% 126